Corporate ActionAug 4, 2026, 08:52 PM
Attovia Therapeutics Prices Upsized IPO of 17M Shares at $17.00, Raising $289M
AI Summary
Attovia Therapeutics, Inc. announced the pricing of its upsized initial public offering, consisting of 17,000,000 shares of common stock at an initial public offering price of $17.00 per share. This offering is expected to generate gross proceeds of $289.0 million for the clinical-stage biopharmaceutical company. The company's common stock is anticipated to begin trading on the Nasdaq Global Market on August 5, 2026, under the symbol "ATTO", with the offering expected to close on August 6, 2026.
Key Highlights
- Attovia Therapeutics priced its upsized initial public offering.
- The offering consists of 17,000,000 shares of common stock.
- Initial public offering price is set at $17.00 per share.
- Gross proceeds from the offering are expected to be $289.0 million.
- Underwriters have a 30-day option to purchase up to an additional 2,550,000 shares.
- Common stock is expected to begin trading on Nasdaq on August 5, 2026, under "ATTO".
- The offering is expected to close on August 6, 2026.
Price Impact
More from ATTO